were controlled with antiepileptic medication. The patient underwent an occipital transtentorial approach to the dorsal midbrain for open biopsy and tissue diagnosis of the mass.
Histopathological Analysis. Histopathological examination of the mass revealed an infiltrate of large plump histiocytes with abundant eosinophilic cytoplasm and reniform nuclei ( Fig. 2A) , including binucleated and multinucleated forms. An associated inflammatory infiltrate was composed of lymphocytes and prominent eosinophils (Fig. 2B ). Immunohistochemical staining revealed the histiocytes were immunoreactive for CD68, S100, and fascin, and a subpopulation were immunoreactive for factor XIIIa (Fig. 2C-F ). Histiocytes were negative for CD1a and Langerin (CD207; not shown), and electron microscope examination did not reveal any Birbeck granules. Together, these histopathological and immunohistochemical features were consistent with JXG.
Postoperative Course. Postoperatively, the patient's neurological examination was unchanged. Further workup did not reveal additional disease, which included a skeletal survey and a CT scan of the chest, abdomen, and pelvis, and bone marrow biopsy. A thorough physical examination failed to reveal any cutaneous lesions or deformities. Lumbar puncture did not reveal abnormal cells in the CSF. The patient underwent a course of adjuvant therapy with 6 cycles of monthly clofarabine followed by a maintenance clofarabine regimen.
At 8 months of age, and 7 months after surgery, the patient was doing well with mild developmental delay, and was improving with physical and occupational therapy. Magnetic resonance imaging of the brain performed after 6 cycles of clofarabine showed a decrease in the size of several of the enhancing intracranial lesions, but persistence in thickening of the optic nerves, chiasm, and hypothalamus (Fig. 3) .
Discussion
Juvenile xanthogranuloma is the most common histiocytic disorder, with the exception of Langerhans cell histiocytosis. 1, 11, 13 This proliferative disorder is typically noted in the first 2 decades of life and is primarily characterized by lesions in the skin or soft tissue in the majority of patients. 5 Males are more commonly affected than females, and most cases are diagnosed in infancy or early childhood, although the solitary cutaneous form may be observed in late childhood. 5, 11, 14 Cutaneous lesions may be single or multiple and are waxy, yellow-red papules with a predilection for the head, neck, and trunk. 5 Approximately 5% of patients present with a single extracutaneous tumor without skin involvement; another 5% of patients present with disseminated disease with involvement of 2 Histiocytes were diffusely immunoreactive for CD68 (C), S100 (D), and fascin (E), and a subset were positive for factor XIIIa (F). Original magnification ×400. or more visceral organs, in addition to skin manifestations. 5, 11, 14 Although extracutaneous manifestations are rare, common sites of involvement include the CNS, liver, spleen, and lungs. 11 The clinical course of JXG is benign in the majority of cases with spontaneous involution of cutaneous lesions. 9 Disseminated disease remains very rare but may have a more malignant course; significant complications and death from acute hepatic failure and thrombocytopenia have been reported.
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Intracranial involvement is a common site of extracutaneous and extraosseous involvement in the systemic form of the disease; however, the incidence of intracranial JXG without cutaneous or other systemic manifestations is very rare. Our review of the literature revealed only 11 other reported cases of intracranial JXG without extracranial manifestations, and 24 total cases of intracranial JXG (Table 1 ). Our literature search was limited to English literature reporting intracranial mass lesions; papers without sufficient clinical information, as well as those reporting purely osseous lesions, were excluded. Ten of the 11 patients with intracranial manifestations without systemic disease were single, isolated intracranial lesions. Only 1 other case (Boström et al.) was previously reported with multiple intracranial lesions without extracranial manifestations. 3 We also report the youngest case of isolated intracranial JXG and document the rapid development of extensive lesions over a period of 6 weeks, as this patient underwent MRI that did not show lesions at birth. Although subtle, the abnormal midbrain enhancement observed in the midbrain at birth may be evidence of active disease at birth without systemic manifestations. There are reports of newborns diagnosed with JXG, but they have all presented with cutaneous manifestations or coagulopathy, and liver failure due to liver lesions. 5, 16 Nakatani et al. 16 have reported a case of a newborn with JXG found to have multiple cutaneous lesions, pancytopenia, coagulopathy, and obstructive liver failure. Upon further imaging, this patient was also found to have a large, right hip tumor, temporal subcutaneous lesion, and solitary left cerebellopontine angle brain lesion. We present the youngest reported case of isolated, multifocal intracranial JXG.
The case we report is also unusual because there was clinical and radiographic evidence of CSF dissemination with hydrocephalus and diffuse infiltration of the optic nerves, chiasm, and tracts. This behavior has rarely been reported. Ernemann et al. 8 reported the case of an 18-year-old female who presented with evidence of extensive dissemination of JXG in CSF without any cutaneous findings, with intracranial hypertension, enhancement of multiple cranial nerve roots, and a subependymal nodule in the right lateral ventricle. This patient experienced rapid progression of JXG despite medical treatment, extensive spread throughout her spine, and succumbed to death. Orsey et al. reported the case of an 11-year-old boy with papilledema and elevated pressure on lumbar puncture, initially diagnosed with pseudotumor cerebri, who was found to have diffuse leptomeningeal infiltration but no mass lesion. 18 Juvenile xanthogranulomatosis was diagnosed in this patient after a meningeal biopsy. Despite treatment, the patient succumbed to this disease and was found at autopsy to have diffuse infiltration of the leptomeninges, brain, spine, abdominal and pelvic serosal surfaces, and bone marrow by a histiocytic sarcoma.
Because this is a relatively rare disease process, little evidence exists to guide the management of intracranial JXG. The majority opinion is that symptomatic, isolated, surgically accessible lesions should be resected. Patients with inaccessible or multiple lesions can be treated with corticosteroids, chemotherapy, radiation, or a combination of these treatments. 3, 21 More data are needed to determine the efficacy of these treatments for intracranial JXG.
Conclusions
Juvenile xanthogranulomatosis is a histiocytic proliferative disorder that can affect a multitude of organ systems. We report the unusual case of a 6-week-old male with disseminated intracranial JXG with multiple tumor foci and evidence of CSF spread. This case is also noteworthy because the lesions appeared over a period of 6 weeks and the patient was without any cutaneous or systemic manifestations.
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